Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -23,625
▼ 470% vs 2024
Profit
Caution€ -27,919
▲ 45% vs 2024
Debts
High€ 237,699
▲ 4% vs 2024
Deep Medicine from Beveren-Kruibeke-Zwijndrecht, company number BE0772322413, closed financial year 2025 with a result of € -27,919 after tax. For that financial year Deep Medicine recorded a gross margin of € -23,625 and equity of € -59,830. Compared with financial year 2024, the result moved from € -50,565 to € -27,919. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
What happened at Deep Medicine?
What happened at Deep Medicine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 27,919. Source: NBB ↗
- Perpetuum Ventures NV became a director. NBB
- Cobagest CommV became a director. NBB
- Tom De Bast stepped down as director. NBB
- James Troch stepped down as director. NBB
- New establishment in Oud-Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,813 loss in 2022 to € 27,919 loss in 2025.
A new publication or filing at Deep Medicine? We notify you, reason included.
Follow Deep MedicineNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Deep Medicine are Perpetuum Ventures NV and Cobagest CommV. The same people are also behind Venture Campus Management and VENTURE CAMPUS.
Directors
According to the 2025 annual accounts
Director · represented by James Troch
Also active at: Venture Campus Management
since 2026
Director · represented by Tom De Bast
Also active at: VENTURE CAMPUS, Venture Campus Management
since 2026
· until 2026
· until 2026
Establishments
Establishment units
Physical locations of this company
Schaarbeekstraat(MEL) 20E box 11
9120 Beveren-Kruibeke-Zwijndrecht
Guldenweg 7
2360 Oud-Turnhout
Active since 6 August 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
MARCEL DE VOS & C°
€ -1.1 million gross margin · 2025
CINERGY EUROPE
€ 4,933 gross margin · 2025
247 Energy same network
€ 260,525 gross margin · 2025
Cartière
€ 683,067 gross margin · 2025
247 Alpha same network
€ 205,802 gross margin · 2025
+3 more
Details
- Company number
- 0772.322.413
- VAT number
- BE 0772.322.413
- Registered office
- Schaarbeekstraat(MEL) 20E bus 11, 9120 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- Deep Medicine
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 August 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Organisatie van congressen en beurzen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige gespecialiseerde wetenschappelijke en technische activiteiten